Curapel
2011
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$551K
LATEST DEAL AMOUNT
4
INVESTORS
Description
Operator of a healthcare company intended to offer medicinal treatments for inflammatory skin diseases. The company's healthcare process develops oral and cream based medicinal products for the treatment of skin pigmentation conditions, enabling consumers to get new treatments for eczema and psoriasis as well as skin pigmentation conditions.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
- Life Sciences Hub Wales
- 3 Assembly Square
- Cardiff Bay CF10 4PL
- Wales, United Kingdom
+44 07866 000000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Curapel’s full profile, request a free trial.
Curapel Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 11-Apr-2016 | $551K | 00000 | 00.000 | Completed | Startup |
| 2. Angel (individual) | 14-Jun-2014 | 00000 | 00000 | 00.000 | Completed | Startup |
| 1. Grant | $32.6K | Completed | Startup |
Curapel Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Pref | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
| Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Curapel Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Development Bank of Wales | Lender/Debt Provider | Minority | 000 0000 | 000000 0 | ||
| Lancaster Capital | Angel Group | Minority | 000 0000 | 000000 0 | ||
| Biotechnology and Biological Science Research Council | Limited Partner | 000 0000 | 000000 0 | |||
| University of Manchester Intellectual Property | Other | 000 0000 | 000000 0 |
Curapel Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Peter Luebcke Ph.D | Board Member, Co-Founder & Chief Executive Officer | ||
| Neil Gibbs Ph.D | Board Member, Co-Founder & Chief Technology Officer |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »